Y. Wu

Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy: Observations Based on Real-World Data.

D. Irwin, K. Cappell, A. Grinspan, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

China's health care sector in transition: resources, demand and reforms.

Y. Wu, 1997, Health policy.

Adherence to Glatiramer Acetate 40 Mg Versus Oral Disease-Modifying Therapies for Multiple Sclerosis.

C. Blauer-Peterson, R. Halpern, R. Wolbeck, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.